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Abstract
Background: From 2007 to 2013, intensive control measures reduced malaria burden by 90 % along the
China-Myanmar border. However, despite these measures a P. falciparum malaria outbreak was reported in
the Shan Special Region II of Myanmar in June of 2014.
Methods: Epidemiological, parasitological and entomological investigations were performed. Dihydroartemisinin
piperaquine (DAPQ) was immediately administered to treat parasite positive individuals. Long lasting insecticidal nets
(LLIN), indoor residual spraying (IRS) with insecticides and behavior change communication (BCC) were also provided
for outbreak control. An embedded efficacy study was conducted evaluating DP. Molecular genotyping via
polymerase chain reaction (PCR) was performed on the Kelch gene on chromosome 13.
Results: All infections were identified as Plasmodium falciparum by RDT and microscopy. Two fatalities resulted
from the outbreak. The attack rate was 72.8 % (67/92) and the incidence density rate was 14.2 per 100 person-weeks.
The positive rate of rapid diagnostic test (RDT) was 72.2 % (65/90) and microscopically-determine parasite rate 42.2 %
(38/90). Adjusted odds ratio (OR) of multivariate logistic regression analysis for aged <15 years, 15–45 years,
inappropriate treatment from a private healer and lack of bed nets were 13.51 (95 % confidence interval,
2.21–105.89), 7.75 (1.48–44.97), 3.78 (1.30–46.18) and 3.21(1.21–15.19) respectively. In the six surrounding
communities of the outbreak site, positive RDT rate was 1.2 % (4/328) and microscopically-determine parasite
rate 0.6 % (2/328). Two light traps collected a total of 110 anopheline mosquitoes including local vectors, An.
minimus, An. sinensis and An. maculates. After intensive control, the detection of malaria attacks, parasites and
antigen were reduced to zero between July 1 and December 1, 2014. The cure rate of P. falciparum patients at
day 42 was 94.3 % (95 % CI, 80.8–99.3 %). The PCR did not detect K13-propeller mutations.
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Conclusion: Imported P. falciparum caused the outbreak. Age, seeking inappropriate treatment and lack of bed
nets were risk factors for infection during the outbreak. P. falciparum was sensitive to treatment with DAPQ. The
integrated measures controlled the outbreak and prevented the spread of P. falciparum effectively. The results
of this study indicate that malaria control on the China-Myanmar border, especially among special populations,
needs further collaboration between China, Myanmar and international societies.
Keywords: Malaria outbreak, Plasmodium falciparum, Investigation, Control, Chinese-Myanmar border
Multilingual abstracts
Please see Additional file 1 for translations of the
abstract into the six official working languages of the
United Nations.
Background
Remarkable progress has been achieved in reducing
malaria cases and deaths over the last decade. The
malaria target under the Millennium Development
Goal 6 has been met, and 55 countries are on track to
reduce their malaria burden by 75 %, in line with the
World Health Assembly’s target for 2015 [1]. The 34
countries have either declared a national policy for
malaria elimination or are pursuing spatially progres-
sive elimination within their borders [2, 3]. Countries
in the Asia Pacific region are making substantial progress
towards eliminating malaria [4], with China aiming to
eliminate malaria by 2020 [5]. However, an estimated 3.2
billion people are still at risk of being infected with
malaria and developing the disease, and 1.2 billion are at
high risk (>1 in 1 000 chance of getting malaria in a year)
across the world [1]. The Greater Mekong Subregion
(GMS) consisting of Cambodia, Yunnan Province of
China, Laos, Myanmar, Thailand and Vietnam, has been
one of the most dangerous foci for malaria. Around 70 %
of the total population of this region are still at risk of
contracting malaria, with 26 % at high risk [6, 7]. Of the
six countries in the GMS, Myanmar has the highest
malaria burden and ranks 31st for countries with the
highest malaria burden globally [6, 8]. Meanwhile, the
emergence of P. falciparum partial resistance to artemisi-
nin has been one of the most concerning issues [1, 9–13].
With the nascent goal for regional malaria elimination
in the GMS, arises the need to develop regional and
local initiatives. Malaria control along the international
border and attempts to contain drug resistance have re-
ceived much attention, but effective interventions remain
challenging [1, 5, 9]. China has prioritized the control of
cross-border transmission of malaria along the 2185 km
China-Myanmar border [14]. During 2007–2013, with the
support of the Global Fund to Fight AIDS, Tuberculosis
and Malaria (GFATM), intensive efforts have reduced
malaria burden by 95 % on the Chinese side and by 89 %
in Myanmar’s border areas [15–17]; meanwhile, the drug
susceptibilty of malaria parasites has not significantly
changed in those areas [18, 19]. In the Shan Special
Region II (locally called Wa State) of Myanmar, malaria
is effectively controlled with parasite prevalence de-
creasing from 11.9 % in March 2008 [16] to 0 % in
November 2013 [17]. However, on June 19th, 2014, a P.
falciparum malaria outbreak was reported in the Aidao
Rubber Plantation, located close to the border. Officials
from China, Myanmar and Health Poverty Action
(HPA) jointly conducted the outbreak investigation and
led the control efforts. Here is reported the outbreak
investigation, the public health response and the efficacy
results from an integrated efficacy study along with a dis-
cussion on the implications of our findings.
Methods
Outbreak site
The outbreak was reported in a private rubber planta-
tion, Aido Rubber Plantation (ARP), about 10 km away
from the China-Myanmar border. The plantation was
established in 2004. At the time when the outbreak was
reported, there were 122 inhabitants, in 24 households
of which 14 families were of the Lahu ethnic minority
who emigrated from Lancang County, China in 2004.
There were 10 families of the Wa ethnic minority who
emigrated from other villages of the Shan Special region
of Myanmar in 2005. All houses have wood and bamboo
walls and grass or asbestos roofs that enable easy entry
for mosquitoes. There were only three bed nets in the
whole community. The Health Center of Tenglong Rubber
Company (HCTRC) is approximately 8 kilometers away
from ARP and is the nearest public health facility.
Additionally, there is a private healer at Rubber Planta-
tion 18 about 2 kilometers away from ARP (Fig. 1).
Outbreak investigation
Focus identification
Four patients from the same family visited the HCTRC
on June 18th, 2014. Three of the four were diagnosed
with P. falciparum infection by microscopy. This was
immediately reported by the HCTRC to the Wa State
Office of the HPA. To better identify the focus of the
outbreak, the HPA examined 50 individuals who actively
requested malaria screening with rapid diagnostic test
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(RDT) on the morning of June 19. The results were re-
ported to Wa State Department of Health in Myanmar;
Kunming office of HPA, Yunnan Institute of Parasitic
Diseases (YIPD) and Menglian Center for Disease Control
and Prevention (CDC) in China (Fig. 2).
Estimation of outbreak size and risk factors
To estimate the size of outbreak, all inhabitants of ARP
were tested by RDT (Standard Diagnostics, FK80 P.f/P.v
RDT, Hagal-Dong, Korea) and axillary temperatures were
measured. Additionally, thick and thin blood smears were
prepared for all subjects including the 50 individuals
previously tested by the HPA with RDT. A standardized
questionnaire to assess risk factors was completed during
a face-to-face interview with each patient or caretaker.
The data were collected from each individual consisting of
age, gender, number and date of malaria attacks, gravity of
attacks, locations from which treatment was sought, re-
sults of RDTs and microscopy, ownership of bed nets and
type of house, and travel excursions between May 1 and
June 19 (Fig. 2).
In addition, a short cross-sectional survey was
conducted from June 21st to 26th, 2014 in all six sur-
rounding communities ranging between 1 and 5 km
from the ARP. The six communities were Bangbai
village, Rubber Plantation 20, Rubber Plantation 18,
Laodaoban village, Waizhai village and Rubber Planta-
tion 17 & 23 (Fig. 1). During the community visits, all
inhabitants who were at home and agreed to take part
in the survey were tested by both RDT and micros-
copy. The questionnaire was not conducted in these
six communities.
Retrospective data collection
Retrospective data was collected to identify the index
case and to acquire contextual knowledge around the
outbreak by reviewing HCTRC records and using non-
directive interviews with private healers and patients
or caretakers who also participated in the standardized
questionnaires.
Outbreak response and control
Diagnosis and case definition
Any patient with a positive RDT was defined as a malaria
case for treatment.
Treatment of cases
DAPQ (40 mg base dihydroartemisinin and 320 mg pipera-
quine phosphate per tablet) was administered to every
malaria case, once a day for 3 days [19]. Patients recruited
into the embedded efficacy study were given directly ob-
served therapy. Other cases were not supervised.
Other outbreak control measures
On June 20, 2014, a total of 61 long lasting insecticidal
nets (LLIN) were distributed to each household in the
outbreak site to isolate malaria patients from uninfected
inhabitants. On the next day, an extra 59 LLINs were
distributed to the six other communities to replace
torn nets. Indoor residual spraying (IRS) with lambda-
cyhalothrin (Syngenta, Jiangsu, China) was carried out
at a dose of 25 mg per m2 to all houses of the ARP,
and houses of malaria patients and their neighbors in
the six surrounding communities on June 27th. Two
community health workers (CHW) were trained and
equipped with RDT and DP to carry out diagnosis and
Fig. 1 Study site relative to neighboring areas
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treatment of malaria. At least one CHW visited the
ARP and its surrounding villages each day from June
21st to August 31st, to actively detect and treat malaria
patients. Behavior change communication (BCC) was
conducted from June 20 to 27, 2014. Investigators
communicated with every patient or caretaker while
they administered a face-to-face interview, and the
CHWs also conducted BCC during their household
visits. The core information of communication included
the cause of malaria, vectors, high risk areas, seeking ap-
propriate diagnosis and treatment, and instruction on the
use of bed nets (Fig. 2). Intensified monitoring by micros-
copy for suspected cases continued at HCTRC until 31
December, 2014.
Entomological survey
At the outbreak site, two light traps (Photocatalysis type,
Kung Fu Xiaoshuai, Wuhan JiXing, China) were used to
collect both indoor and outdoor mosquitoes overnight.
The genus was identified in the field, and anophelines
were sent to laboratory of Menglian CDC for identifica-
tion of species [20].
Embedded efficacy study
Patients and recruiting criteria
Based on the results of microscopy, patients with mono-
infections of P. falciparum, older than 1 year, with a
body weight ≥ 5 kg, and presenting with a parasite density
of 500–100 000 parasites per μL, were recruited to this
study, after obtaining full informed consent. Exclusion
criteria were defined as previously described [21].
Study design
The study design was based on the standard 42 day
follow up survey as defined by the WHO [21, 22]. The
two trained CHWs visited patient homes on day 1, 2
and 3 to give directly observed treatment. Patients were
then assessed at follow up visits on days 7, 14, 21, 28, 35
and 42 or whenever they had signs and symptoms con-
sistent with malaria.
Treatment
DAPQ was sourced from Zhejiang Holley Nanhu
Pharmaceutical Co. Ltd, and provided at 65 mg/kg body
weight.
Fig. 2 Profile for outbreak investigation, response and control in Shan Special Region II of Myanmar, June – December 2014
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Clinical procedures
A general physical exam was conducted at enrollment.
Axillary temperature was measured and blood was
collected for blood smears and filter paper spots (about
100uL blood per patient) at enrollment, every 8–12 h in
the first 3 days and then on day 7, 14, 21, 28, 35 and 42.
Laboratory investigation
Malaria blood films were stained with Giemsa, and slides
were examined by two independent microscopists in
YIPD and considered negative if no parasites were seen
after examination of 200 oil-immersion fields in a thick
blood film. Parasite clearance was defined as no detec-
tion of asexual parasites per 500 white blood cells in two
sequential microscopic examinations within an 8–12 h
interval [19]. PCR was performed in the National Institute
of Parasitic Diseases, China CDC to distinguish between
reinfection and recurrence of blood stage infections by
genotyping and to confirm the Plasmodium species or, if
needed, to detect mixed infections. DNA extraction and
genotype analysis were conducted based on investigation
of the three polymorphic genetic markers msp1, msp2,
and glurp, according to WHO recommended procedures
[19, 23, 24]. Recrudescence was defined as at least one
identical allele for each of the three markers in the pre-
treatment and post-treatment samples. New infections
were diagnosed when all alleles for at least one of the
markers differed between the two samples. Cases with
new infections were censored at the time of occurrence
from the survival analyses. In case of failure after day 7,
patients whose PCR results were unknown were censored
at the time of occurrence from the survival analyses as
well. A nested PCR was used to amplify the Kelch gene on
chromosome 13 following previously reported methods
[25, 26].
Classification standards for treatment outcome
Treatment outcome was categorized based on the
WHO definitions for early treatment failure (ETF),
late clinical failure (LCF), late parasitological failure
(LPF), and adequate clinical and parasitological response
(ACPR) [21].
Statistical analyses
Data were double entered and cleaned in EpiData 3.1
(EpiData Association, Odense, Denmark), and ana-
lyzed in Epi Info 7 (Centers for Disease Control and
Prevention, Atlanta, GA). Attack rate (AR) and inci-
dence density (ID) was calculated using the following
formula [27]:
AR ¼ Numberof persons attacked
Number of persons investigated
 100%
ID ¼ Totalnumber of attacks
Number of persons investigated  number of weeks observed 100
A Chi-squared test was used to compare the propor-
tions and significance was P < 0.05. A multivariate logis-
tic model was used to identify risk factors of malaria
infections during the outbreak. In the model, the out-
come (dependent) variable was the RDT result, and in-
dependent variables were demographic characteristics,
staying overnight in other places, seeking treatment,
ownership of bed net and type of roof [27, 28]. The
Kaplan-Meier method was used to analyze the outcome
of therapeutic efficacy test of DP [18, 19, 21, 22].
Ethical approval
The outbreak investigation and control protocol was ap-
proved by Wa State Department of Health (WDH). Oral
agreements for the outbreak surveys and control interven-
tions were obtained from all individuals. Ethical approval
for in vivo efficacy study was granted by the Ethics
Committee of Yunnan Institute of Parasitic Diseases
(YIPD), China. Informed written consent was obtained
from all adult subjects or caretakers of children who
participated in DP therapeutic efficacy study, and the
participants had the right to withdraw from the study
at any time. All results were kept confidential and were
unlinked to any identifying information.
Results
Outbreak characteristics
The outbreak was reported when three out of four pa-
tients were found to be positive for P. falciparum by mi-
croscopy. In order to better understand the focus of the
outbreak further 50 inhabitants were tested by RDT and
32 (64 %, 95 % CI: 49.2–77.1 %) were found positive.
This result prompted a formal outbreak investigation.
Of the 122 inhabitants of ARP, 92 were investigated.
Two deaths were reported by the private healer and in-
terviewees during the face-to-face interview. 90 (73.8 %)
suspected cases were tested with both RDT and micros-
copy. Questionnaires were administered in all 90 sub-
jects (Table 1). The four initially tested cases and the 50
tested with RDT by HPA were reexamined by micros-
copy and administered with questionnaires, and thus
were included in the 90 total subjects to complete the
questionnaire.
The median age was 22.9 years (rang: 3 months-
70 years). The male/female sex ratio was 0.96 (Table 1).
As a result of the retrospective data collection, the first
malaria patient, a 52-year male, was diagnosed by the
private healer on May 17 and died on May 27. He had
been mining for gold in Salween River Valley and returned
back to ARP on May 8; the second fatality, 23-year male,
occurred on June 14, but he had never been out of ARP.
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The both fatalities were Lahu ethnic minority, and they
presented the symptoms of complicated malaria including
shivering, high fever, severe headache, hematuria, abnor-
mal posturing, nystagmus and coma.
Out of the 90 suspected cases tested by RDT and mi-
croscopy, 65 (72.2 %) were positive for P. falciparum by
RDT and 38 (42.2 %) were found positive by microscopy
(x2 = 14.91, P < 0.01). From the 65 RDT positive subjects,
30 (46.2 %) were male and 27 (41.6 %) children
(<15 years) (Table 1).
To estimate the size of the outbreak, a total of 328
volunteer participants from the six surrounding commu-
nities were screened by both RDT and microscopy in a
short cross–sectional survey. The median age of the sub-
jects was 21.0 years (rang: 1 month - 80 years). The
male/female sex ratio was 0.8. Four (1.2 %) individuals
were found positive for P. falciparum by RDT, three of
them were from Banbai village, which is approximately 1
kilometer away from the centre of the outbreak. The
fourth case was from Laodaoban village, which is two
kilometers away from ARP. All 328 subjects did not
report being overnight in other places from May 1st to
June 19th.
Risk factors
Data to determine risk factors was collected in struc-
tured questionnaires from 90 participants. A multivariate
logistic regression analysis (MLRA) identified seeking
treatment from the private healer (OR 3.78, P < 0.01)
and lack of bed nets (OR 3.21, P < 0.05) were associated
with malaria infection during the outbreak. The most
important risk factor was age <15 years with an OR of
13.5 (P < 0.01) (Table 2). Data collected in the unstruc-
tured interviews confirmed these findings. Many respon-
dents reported that the private healer was their first
choice when they were ill. The private healer just admin-
istered a single artemether injection as treatment. The ill
persons also said that they did not go for more injec-
tions when they felt well unless they had another
attack, resulting in a less-than-three-day artemether
regimen (a standard artemether regimen for malaria
treatment should be 5 days). The respondents also re-
ported that no health staff had visited ARP until the
outbreak, and they had never received bed nets prior.
Attack rate and results of outbreak response and control
During the outbreak, prior to the first intervention, the
attack rate and incidence density were 60.7 % (56/92)
and 15.9 per 100 person-weeks respectively. After the
intervention this fell to 12.2 % (11/90) and 8.9 per 100
person-weeks (Fig. 3). The response decreased the inci-
dence density significantly (χ2 = 3.99, P < 0.05) and rap-
idly, within 10 days. There were no malaria attacks
found after July 1st. The trained CHWs were unable to
find any individuals with parasites and/or that were RDT
positivity in ARP and the six surrounding communities.
Furthermore, malaria has not been found in those com-
munities until December 31st 2014.
Entomological results
From 8:00 pm of June 20th to 7:00 am of June 21st
(11 h), 110 of anopheline mosquitoes were collected.
The light traps collected nine anopheline mosquitoes in-
doors including one (11.1 %) An. minimus and four
(44.4 %) An. sinensis, and 101 anopheline mosquitoes out-
doors including eight (7.9 %) An. minimus, 20 (19.8 %)
An. maculates and 20 An. sinensis (Table 3).
Table 1 Baseline characteristics of subjects in the outbreak site
and its six surrounding communities, Shan Special Region II,
Myanmar
Characteristics Number (%, 95 % CI)
Subjects in ARP (n = 92)
Male 44 (47.8, 37.3–58.5)
Age < 5 years 12 (13.0, 6.9–21.7)
Age 5–14 years 20 (21.7, 13.8–31.6)
Age ≥15 years 60 (65.2, 54.6–74.9)
Overnight in other places, May 1-June 19, 2014 12 (13.0, 6.9–21.7)
Seek treatment from the private healer 59 (64.1, 53.5–73.9)
Subjects with RDT positivity in ARP (n = 65)
Male 30 (46.2, 33.7–59.0)
Age < 5 years 12 (18.5, 9.9–30.0)
Age 5–14 years 15 (23.1, 13.5–35.2)
Age ≥15 years 38 (58.5, 45.6–70.6)
Overnight in other places, May 1-June 19, 2014 8 (12.3, 5.5–22.8)
Seek treatment from the private healer 49 (75.4, 63.1–85.2)
Subjects with parasites in ARP (n = 38)
Male 20 (52.6, 35.8–69.0)
Age < 5 years 8 (21.1, 9.6–37.3)
Age 5–14 years 10 (26.3, 13.4–43.1)
Age ≥15 years 20 (52.6, 35.8–69.0)
Overnight in other places, May 1-June 19, 2014 5 (13.2, 4.4–28.1)
Seek treatment from the private healer 20 (52.6, 35.8–69.0)
Axillary temperature (°C), Mean ± SD (rang) 37.1 ± 0.8 (36.1–39.2)
Parasite count (per uL), Geometric mean (rang) 24268 (860–99667)
Subjects in six surrounding communities (n = 328)
Male 144 (43.9, 38.5–49.5)
Age < 5 years 46 (14.0, 10.5–18.3)
Age 5–14 years 95 (29.0, 24.1–34.2)
Age ≥15 years 187 (57.0, 51.5–62.4)
Overnight in other places, May 1-June 19, 2014 0 (0, 0–1.1)
RDT positivity 4 (1.2, 0.3–3.1)
P. falciparum 2 (0.6, 0.1–2.0)
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Therapeutic efficacy of DAPQ
A total of 35 of 38 confirmed P. falciparum patients
were recruited into the embedded DAPQ therapeutic effi-
cacy trial. There were a total of two treatment failures,
one LCF and one LPF. No patients were lost to follow up.
The cure rate at day 42 was therefore 94.3 %, (95 % CI,
79–98.5 %) (Table 4. PCR identified the LCF and LPF as
recrudescence on day 14 and 21 respectively, and the
PCR-adjusted cure rate is therefore the same as the un-
adjusted. Both patients received a second course of DAPQ
and were followed up further, without detecting parasites
anymore. The fever clearance time (FCT) and asexual
parasite clearance time (APCT) were, respectively, 36.4 ±
8.9 and 53.3 ± 11.3 h. K13-propeller mutations were not
detected in these parasite samples.
Discussion
The purpose of the paper is to present the outbreak in-
vestigation, the public health response, DAPQ sensitivity
in P. falciparun, cause analysis of the outbreak and im-
plications of the findings.
According to the report from the private healer and
the face-to-face interview, the gold miner was the first
patient, and he died on May 27th. The interviews also
found that patients usually visited the private healer
and received less than 3-day artemether injection. The
results of the parasitological investigation showed that
the RDT positive rate (72.2 %) was much higher than
the microscopically-determined parasite rate (38.9 %).
As all slides were reexamined by two expert microsco-
pists in YIPD and the RDT (SD FK80 P.f/P.v Malaria
Antigen Rapid Diagnostic Test) detects histidine-rich
protein-2 (HRP2) of P. falciparum and specific lactate
dehydrogenase (Pv-pLDH) of P. vivax [29], one explan-
ation for the discordance between detection methods is
the private healer did not follow the required treatment
course, and administered less than 3-day artemether
injection. This sub-dosing of artemether decreased the
P. falciparum parasitemia to sub-microscopy levels, but
did not clear parasites and interrupt transmission com-
pletely. In addition, HRP2 is detectable by RDT for about
2 weeks after parasite clearance [30]. As the HRP2 in
some patients treated with artemether was still at detect-
able levels by RDT when the investigation was conducted,
the RDT positive rate might indicate a more accurate
measure of the true prevalence of P. falciparum infections.
The PCR identified that all 35 parasite samples belonged
to the same msp1, msp 2 and glurp genotype. The ento-
mological survey found An. minimus and An. sinensis
indoors; and a certain proportion of An. maculates, An.
sinensis and An. minimus outdoors. An. minimus is consid-
ered the local principle vector; An. sinensis is a secondary
Table 2 Results of multivariate logistic regression analysis for risk factors during the outbreak, Aidao Rubber Plantation, Shan Special
Region II of Myanmar (N = 90)
P. falciparum (%, 95 % CI) RDT positivity (%, 95 % CI) OR (95 % CI) P-value Adjusted OR (95 % CI) P-value
Sex
Female (n = 48) 20 (41.7, 27.6–56.8) 33 (68.8, 53.7–81.3) 1 - 1 -
Male (n = 42) 18 (42.9, 27.7–59.0) 32 (76.2, 60.5–87.9) 1.45 (0.52–4.12) 0.5821 1.27 (0.40–4.39) 0.6120
Age (years)
46–74 (n = 11) 2 (18.1, 2.3–51.8) 3 (27.3, 6.0–61.0) 1 - 1 -
15–45 (n = 47) 18 (38.3, 24.5–53.6) 35 (74.5, 59.7–86.1) 7.78 (1.50–45.18) 0.0052 7.75 (1.48–44.97) 0.0049
0–14 (n = 32) 18 (56.3, 37.7–73.6) 27 (84.4, 67.2–94.7) 14.4 (2.27–107.82) 0.0010 13.51 (2.21–105.89) 0.0013
Overnight in other places from May 1 to June 19, 2014
Yes (n = 12) 5 (15.2, 5.1–31.8) 8 (66.7, 34.9–90.1) 1 - 1 -
No (n = 78) 33 (42.3, 31.2–54.0) 57 (73.1, 61.8–82.5) 1.36 (0.30–5.74) 0.7316 1.08 (0.25–47.32) 0.8154
Seeking treatment from the private healer within 10 days
No (n = 31) 18 (58.1, 39.1–73.6) 16 (51.6, 33.1–69.8) 1 - 1 -
Yes (n = 59) 20 (33.9, 22.1–47.4) 49 (83.2, 71.0–91.6) 4.59 (1.55–13.77) 0.0035 3.78 (1.30–46.18) 0.0045
Ownership of bed nets
Yes(n = 16) 4 (25.0, 7.3–52.4) 7 (43.8, 19.8–70.9) 1 - 1 -
No(n = 74) 34 (45.9, 34.3–57.9) 58 (78.4, 67.3–87.2) 4.66 (1.31–16.80) 0.0125 3.21 (1.21–15.19) 0.0157
Type of roof
Asbestos tile (n = 13) 3 (23.1, 5.0–53.8) 8 (61.5, 31.6–86.1) 1 1 -
Grass (n = 77) 35 (45.5, 34.1–57.2) 57 (74.0, 63.3–82.9) 1.78 (0.44–7.01) 0.3400 1.59 (0.50–9.18) 0.4152
Note: RDT positivity is the outcome (dependent) variable
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vector and An. maculates is an important vector in the
GMS [20]. These results show that the gold miner intro-
duced P. falciparum to the existing vectors, and that the
existing vectors were able to reestablish transmission.
The multivariate logistic regression analysis (MVLRA)
identified that age, seeking inappropriate treatment and
lack of bed nets were risk factors during the outbreak.
Children less than 5 years accounted for 32.3 % of total
65 RDT positive subjects. This indicated that children,
especially less than 5 years, were at the highest risk dur-
ing the outbreak. While the sixth and tenth rounds of
the GFATM’s China Malaria Program covered the Shan
Special Region II of Myanmar, the malaria control pro-
grams neglected the ARP. As the ARP was a unique
community consisting of the illegal, Chinese-immigrant
Lahu people and the internal, Myanmar-immigrant Wa
people, the inhabitants were too poor to seek appropri-
ate diagnosis and effective treatment. Their first choice
was to visit the private healer when they were ill. The
private healer incorrectly administered a single arte-
mether injection for malaria treatment and the ARP
inhabitants did not return for the additional injections if
they felt well. This led to artemether injection for less
than 3 days. This sub-therapeutic dose of artemether
relieved symptoms of malaria patients, but allowed re-
sidual parasites to maintain transmission and establish
the outbreak. Additionally, the malaria control programs
routinely distributed LLINs resulting in one net per two
persons, however, the ARP had never received any
LLINs prior to the outbreak, thus preventing protection
from the mosquito vector.
Table 3 Results of entomological investigation in the outbreak
site, Aidao Rubber Plantation, Shan Special Region II of
Myanmar
Density (per lamp-night) % (% CI)
Indoor (n = 9)
An. minimus 1 11.1 (0.3–48.2)
An. annularis 4 44.4 (13.7–78.8)
An. sinensis 4 44.4 (13.7–78.8)
Outdoor (n = 101)
An. minimus 8 7.9 (3.5–15.0)
An. annularis 50 49.5 (39.4–59.6)
An. maculatus 20 19.8 (12.5–28.9)
An. splendidus 3 3.0 (0.6–78.8)
An. sinensis 20 19.8 (12.5–28.9)
Fig. 3 Incidence Chart of falciparum malaria (number of patients, attacks and death) for the outbreak in Shan Special Region II of Myanmar,
June – December 2014
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The life cycle of P. falciparum is assumed to last about
10 days [31]. In this case, the peak of incidence from
June 16th to 20th would indicate the third generation of
patients from the initial outbreak (Fig. 3). As one would
expect, the last patient to contract the disease appeared
on June 30, i.e. 10 days after the emergence response.
This showed the response was both timely and effective.
According to the Chinese Ministry of Health’s strategy
for approaching malaria outbreaks, mass drug adminis-
tration (MDA) should be targeted to communities with
recent outbreaks [31]. DAPQ was only administered to in-
dividuals with a positive RDT, however, two trained CHWs
were equipped with RDT and DP, and conducted daily
visits to the outbreak site and its surrounding commu-
nities. These CHWs conducted active detection and
treated RDT positive patients immediately. Meanwhile,
LLIN, IRS and BCC interventions were conducted in
parallel. These control measures were effective as P.
falciparum was just detected in two individuals, and
there were only four positive RDTs in the six surround-
ing communities after the interventions. The strategy,
with the noted absence of out MDA, had controlled the
outbreak and prevented P. falciparum from spreading in
the six surrounding communities. This success is likely at-
tributed to active collaboration and joint efforts of China,
Myanmar and international NGOs as well as strong com-
munity involvement.
DAPQ was the most commonly used ACT in malaria
programs on the China-Myanmar border. While artemi-
sinin resistance has extended across much of Myanmar
[26], the results of the embedded efficacy study showed
that the P. falciparum in this outbreak was still sensitive
to DAPQ and that DAPQ was effective for the treatment
of this outbreak, noting the absence of K13-propeller
mutations in these parasite samples. Additional to this
observation, the results of in vivo monitoring from 2007
to 2013 that indicate that P. falciparum was sensitive to
DAPQ along China-Myanmar border [19], demonstrate
the ongoing success of China’s strategy to control cross-
border transmission of malaria and contain artemisinin
resistance. However, this outbreak warns that malaria
may resurge at any time as long as control activities
weaken. Inappropriate treatments with sub-therapeutic-
dosage and/or mono-therapies contribute to maintain
malaria transmission and are thus harmful to patient
prognosis and public health and also a cause of drug
resistance [9]. While the emergence of artemisinin resist-
ance in Southeast Asia is threatening the global control of
P. falciparum malaria [25], these inappropriate treatments
threaten to undermine usefulness of ACTs in areas that are
unaffected by resistance.
Several lessons can be learned from the outbreak. First,
particular attention should be given the transient and
neglected groups. The lack of effective interventions and
surveillance among neglected populations may lead to
outbreaks or even a resurgence of malaria. Second, in-
appropriate diagnoses and treatments still exist in the
private sector on the China-Myanmar border. Coverage
and service of public health facilities should be increased
and strengthened to allow access to easy alternative to
private healers. Additionally, the ban of sale of fake and
sub-standard antimalarial drugs, including artemisinin
monotherapy should be more thoroughly enforced. Third,
as the GFATM terminated the tenth round of its malaria
program by December 31st, 2013, the outbreak occurred
during the transition phase from China’s to Myanmar’s
malaria program when surveillance and interventions
were the weakest. Taken together, these lessons show that
collaboration between China, Myanmar and international
societies for malaria control should be strengthened and
improved.
It is noted that the entomological survey is one limita-
tion of his study as the collection of anopheline mosqui-
toes was only carried out by two light traps for one
night, and human landing collection was not carried out.
Entomological data of local malaria vectors are still lacking
in Shan Special region II of Myanmar, and further re-
search may be needed. However, the light traps were suc-
cessful in collecting local malaria vectors including: An.
minimus, An. maculate and An. sinensis. This provided
evidence for inclusion of LLINs and IRS as part of out-
break response.
Table 4 Therapeutic responses of patients to dihydroartemisinin-piperaquine, Shan Special Region II, Myanmar (n = 35)
Indicator Value
Fever clearance time (hr), Mean (± SD) 36.4 (8.9)
50 % asexual parasite clearance time (hr), Mean (± SD) 25.2 (7.8)
Asexual Parasite clearance time (hr), Mean (± SD) 53.3 (11.3)
Early treatment failure, number (%, 95 % CI) 0 (0,0–6.7)
Late clinical failure, number (%, 95 % CI) 1 (2.9, 0.07–14.9)
Late parasitological failure, number (%, 95 % CI) 1 (2.9, 0.07–14.9)
Adequate clinical and parasitological response, number (%, 95 % CI) 33 (94.3, 79.0–98.5)
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Conclusion
This investigation confirmed, contained, and characterized
P. falciparum malaria outbreak. Age, seeking inappropri-
ate treatment and lack of bed nets were risk factors of
malaria infection during the outbreak. K13-propeller mu-
tations were not found in the P. falciparum parasites and
DAPQ was demonstrably effective in treating infections.
Treatment of malaria cases, combined with LLIN distribu-
tion, IRS and BCC, successfully controlled the outbreak
and prevented the spread of P. falciparum. On the
China-Myanmar border, malaria control, especially
among special populations, needs further collaboration
between China, Myanmar and international societies.
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